Evidence map›Paper›PMID 32870413›Full record

SynthesisSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2021

Dealing with the lack of evidence to treat depression in older patients with cancer: French Societies of Geriatric Oncology (SOFOG) and PsychoOncology (SFFPO) position paper based on a systematic review.

Bérengère Beauplet, Ophélie Soulie, Jean-Yves Niemier, Cécile Pons-Peyneau, Drifa Belhadi, Camille Couffignal, Virginie Fossey-Diaz

Abstract readSystematic ReviewConsensus Statement
PubMed Publisher
In one paragraph

Synthesis in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Bérengère BeaupletNormandy Interregional Oncogeriatric Coordination Unit, Rue Bailey, 14000, Caen, France. beauplet-b@chu-caen.fr.ORCID http://orcid.org/0000-0002-7790-4556
Ophélie SouliePsycho-Oncology Unit, Supportive Care Department, Curie Institute, 75005, Paris, France.
Jean-Yves NiemierDepartment of Geriatric Oncology, Nancy University Hospital Center, 54511, Vandoeuvre-lès-Nancy, France.
Cécile Pons-PeyneauDepartment of Psychiatry, Chardon-Lagache Hospital, 75016, Paris, France.
Drifa BelhadiBiostatistics and Clinical Research Unit, AP-HP Northern Group, Bichat-Claude Bernard Hospital, Paris, France.
Camille CouffignalBiostatistics and Clinical Research Unit, AP-HP Northern Group, Bichat-Claude Bernard Hospital, Paris, France.
Virginie Fossey-DiazDepartment of Geriatric Medicine and Palliative Care, Bretonneau Hospital Center, 75018, Paris, France.

Funding

Institut National Du Cancer UCOG
6 · The paper itself

Abstract

introductionDepression symptoms, frequently diagnosed in older patients with cancer, impacts on oncological treatment feasibility. The Francophone Society of Geriatric Oncology (SOFOG) has initiated a systematic review on depression treatment in older patients with cancer, to advocate guidelines. DATA SOURCES: Medline via PubMed, Embase, CENTRAL.

methodsWe included randomized and non-randomized controlled trials, reviews and meta-analysis, retrospective and prospective cohort studies, qualitative studies, and guidelines published between January 2013 and December 2018 that involved depression with cancer in which the entire sample or a sub-group aged 65 and above. Efficacy and tolerance of depression treatment were examined, as a primary or secondary outcome, among articles published in French or English.

resultsOf 3171 references, only seven studies met our eligibility criteria. This systematic review reveals a lack of evidence-based knowledge in this field, preventing from making any recommendations on drug and non-drug therapies. It has highlighted the need for multidisciplinary collaboration with the French and Francophone Society of Psycho-Oncology.

conclusionIn clinical practice, we advise health professionals to use the screening process not as a result but rather as an opportunity to engage with the patient and also to question the need for antidepressants and non-drug therapies.

Indexed as

AgedAge FactorsAntidepressive AgentsDepressionHumansMajor Depressive DisorderMeta-Analysis as TopicNeoplasmsProspective StudiesRandomized Controlled Trials as TopicRetrospective StudiesAntidepressive Agents80 and olderAgedDepressionDepressive disorderGeriatricsNeoplasms

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.